Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
NextGen Healthcare sells electronic health records and practice management software to medical and dental offices.
NextGen Healthcare makes the software that runs the front and back office of a doctor's practice. When a patient checks in, when the doctor types notes, when a prescription goes to the pharmacy, and when the bill goes out to the insurance company β that workflow often lives inside NextGen's electronic health record and practice management tools. Its customers are mostly ambulatory care providers: independent physician groups, specialty clinics, community health centers, and dental practices. These are smaller organizations that cannot build their own systems, so they buy software that handles scheduling, billing, clinical documentation, and now telehealth and patient messaging in one place.
The business model is classic healthcare software. Customers pay recurring subscription and licensing fees, plus ongoing support, and NextGen also earns money from related services that help clinics switch over and keep running. That recurring revenue is the prize: once a practice loads years of patient records and trains its staff on a system, ripping it out is painful, so customers tend to stay. The catch is that this is a crowded, competitive market. Rivals range from giant hospital-focused vendors to smaller cloud-native upstarts, and every one of them is trying to win the same independent practices. NextGen's pitch is that it offers a full suite β clinical, financial, and administrative β tuned for outpatient settings rather than one-size-fits-all hospital software. The company has a long, slightly confusing history. It spent years as Quality Systems, Inc. before rebranding as NextGen Healthcare, and it traded on the Nasdaq under the ticker NXGN. That era ended in 2023, when private equity firm Thoma Bravo bought the company and took it private in a deal worth roughly $1.8 billion. So NextGen is no longer a public stock; it is now owned by Thoma Bravo, one of the biggest software-focused private equity investors. Thoma Bravo's playbook is familiar: buy a software company with sticky customers, push it to grow and become more efficient, and eventually sell it or take it public again.
Why does a private equity firm want a company like this? Because healthcare software is about as reliable as business gets β clinics need it every single day, and switching is a headache. The risk is that NextGen operates in a market where bigger players keep consolidating and where cloud-based competitors can undercut older systems. For a practice, the practical question is simple: does the software make billing easier, keep patient data organized, and stay compliant with constant regulatory changes? For Thoma Bravo, the bet is that a well-run NextGen can keep collecting those subscription checks from thousands of medical and dental offices for years to come.
Saved answer Β· last researched 15 Nov 2026